Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Chin CT, Mellstrom C, Chua TS, Matchar DB. Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: a Singapore healthcare perspective. Singapore Medical Journal 2013 Mar; 54(3): 169-175 Indexing Status Subject indexing assigned by NLM MeSH Acute Coronary Syndrome /drug therapy /economics; Adenosine /analogs & Aspirin /administration & Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Drug Costs; Humans; Markov Chains; Platelet Aggregation Inhibitors /administration & Purinergic P2Y Receptor Antagonists /administration & Quality-Adjusted Life Years; Republic of Korea; Singapore; Ticlopidine /administration & derivatives; derivatives /economics /therapeutic use; dosage; dosage /analogs & dosage /economics; dosage /economics AccessionNumber 22013014487 Date bibliographic record published 01/05/2013 |
